Your browser doesn't support javascript.
loading
Can arsenic do anything good? Arsenic nanodrugs in the fight against cancer - last decade review.
Komorowicz, Izabela; Hanc, Anetta.
Affiliation
  • Komorowicz I; Department of Trace Analysis, Faculty of Chemistry, Adam Mickiewicz University in Poznan, 8 Uniwersytetu Poznanskiego Street, 61-614, Poznan, Poland. Electronic address: iza.k@amu.edu.pl.
  • Hanc A; Department of Trace Analysis, Faculty of Chemistry, Adam Mickiewicz University in Poznan, 8 Uniwersytetu Poznanskiego Street, 61-614, Poznan, Poland.
Talanta ; 276: 126240, 2024 Aug 15.
Article in En | MEDLINE | ID: mdl-38754186
ABSTRACT
Arsenic has been an element of great interest among scientists for many years as it is a widespread metalloid in our ecosystem. Arsenic is mostly recognized with negative connotations due to its toxicity. Surely, most of us know that a long time ago, arsenic trioxide was used in medicine to treat, mainly, skin diseases. However, not everyone knows about its very wide and promising use in the treatment of cancer. Initially, in the seventies, it was used to treat leukemia, but new technological possibilities and the development of nanotechnology have made it possible to use arsenic trioxide for the treatment of solid tumours. The most toxic arsenic compound - arsenic trioxide - as the basis of anticancer drugs in which they function as a component of nanoparticles is used in the fight against various types of cancer. This review aims to present the current solutions in various cancer treatment using arsenic compounds with different binding motifs and methods of preparation to create targeted nanoparticles, nanodiamonds, nanohybrids, nanodrugs, or nanovehicles.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Talanta Year: 2024 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Talanta Year: 2024 Document type: Article Country of publication: Países Bajos